Wang Du is a diabetes Research Fellow at the George Institute, China. She is also the Assistant to the Chairman of the International Diabetes Federation (IDF), Western Pacific Region. Let us hear more about her story.
Including fixed dose combinations on Essential Medicine List will improve availability, affordability for 1 billion
The George Institute for Global Health welcomes the addition of fixed dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization’s (WHO) Essential Medicines List (EML) in response to an application filed by Resolve to Save Lives (RTSL), an initiative of vital strategies, the George Institute and other partners.
Co-founder and Principal Director of The George Institute for Global Health, Professor Stephen MacMahon, has been selected as a finalist for the prestigious Eureka Prize for Leadership in Innovation and Science.
Samina Parveen is a Research Fellow at the George Institute for Global Health. She has completed her Master’s in Public Health from Savitribai Phule Pune University and her Bachelor’s in Microbiology/Biochemistry from St. Xavier’s College, Mumbai
Last month we celebrated the contributions of Professor Terry Dwyer to The George Institute for Global Health, UK with speeches over a team lunch and a public seminar (which you can watch back here). Terry is moving on from his position at the University of Oxford, in which he acted as Executive Director of The George Institute in the UK from 2014-18 and focused on research into children’s cancer and childhood risk factors for heart disease and cancer in adults.
Influenza (the ‘flu) is a contagious disease of the respiratory tract caused by influenza viruses. In more than 998 people out of 1000 influenza is a self-limiting illness that does not need any specific treatment other than rest, pain killers such as paracetamol and control of fever. However, in a minority of sufferers it is more serious and may lead to sepsis.
New research provides compelling evidence that long-term exposure to high blood pressure increases the risk of heart valve disease, with significant implications for clinical practice guidelines and health management.